65 Year Old Woman with Schizoaffective Disorder Very Late Onset dan Withdrawal Benzodiazepine
Case Report
DOI:
https://doi.org/10.55175/cdk.v52i1.664Keywords:
Benzodiazepine withdrawal, Schizoaffectice disorder, schizophrenia in elderlyAbstract
Schizoaffective disorder is characterized by a combination of symptoms of schizophrenia and of affective disorders. This paper reports a 65-year-old female with sychotic symptoms and agitation. The patient was diagnosed as bipolar type schizoaffective with benzodiazepine withdrawal based on the presence of symptoms of schizophrenia and mood involvement and a history of abrupt discontinuation of benzodiazepines. Patient carried out daily activities independently even though her social relations are disrupted. Schizoaffective onset over 60 years is very rare. Unspecific symptoms and comorbidities may delay diagnosis.
Downloads
References
Miller 1.JN, Black DW. Schizoaffective disorder: A review. Ann Clin Psychiatry. 2019;31(1):47-53. DOI: 10.3109/10401239109147967.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Wy TJP, Saadabadi A. Schizoaffective Disorder [Internet]. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541012/
Setiawati T, Khairina K, Aini S. Family role on schizoaffective type patients treatment. 2021;10(2):79-82. DOI: https://doi.org/10.20473/jps.v10i2.22857.
Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, et al. Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth. Can J Psychiatry. 2017;62(9):635-47. DOI: 10.1177/0706743717720197.
Tampi RR, Young J, Hoq R, Resnick K, Tampi DJ. Psychotic disorders in late life: A narrative review. Ther Adv Psychopharmacol. 2019;9:2045125319882798. DOI: https://doi.org/10.1177/2045125319882798.
Sharma ER, Debsikdar AV, Naphade NM, Shetty JV. Very late-onset schizophrenia like psychosis: Case series and future directions. Indian J Psychol Med. 2014;36(2):208-10. DOI: 10.4103/0253-7176.130999.
Chien WT, Leung SF, Yeung FK, Wong WK. Current approaches to treatments for schizophrenia spectrum disorders, part II: Psychosocial interventions and patient-focused perspectives in psychiatric care. Neuropsychiatr Dis Treat. 2013;9:1463-81. DOI: 10.2147/NDT.S49263.
Archibald L, Brunette MF, Wallin DJ, Green AI. Alcohol use disorder and schizophrenia or schizoaffective disorder. Alcohol Res. 2019;40(1):arcr.v40.1.06. DOI: 10.35946/arcr.v40.1.06. eCollection 2019.
El-Saifi N, Moyle W, Jones C, Tuffaha H. Quetiapine safety in older adults: A systematic literature review. J Clin Pharm Ther. 2016;41(1):7-18. DOI: 10.1111/jcpt.12357.
Ljubic N, Ueberberg B, Grunze H, Assion HJ. Treatment of bipolar disorders in older adults: A review. Ann Gen Psychiatry. 2021;20(1):45. DOI: 10.1186/s12991-021-00367-x.
Maanen AC, Wilting I, Jansen PA. Prescribing medicines to older people—How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921–30. DOI: 10.1111/bcp.14094.
Bogunovic OJ, Greenfield SF. Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatr Serv. 2004;55(3):233-5. DOI: 10.1176/appi.ps.55.3.233.
Canadian Centre on Substance Abuse. Effective interventions to manage symptoms of benzodiazepine withdrawal in seniors [Internet]. 2014 [cited on 2022 Nov 24]. Available from: https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Benzodiazepine-Withdrawal-Seniors-Rapid-Review-2014-en.pdf.
Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia tentang Pedoman Nasional Pelayanan Kedokteran Jiwa [Internet]. 2015. Available from: https://www.kemkes.go.id/app_asset/file_content_download/170312443765839dd5be6791.97275276.pdf.
Amore M, D’Andrea M, Fagliolini A. Treatment of agitation with lorazepam in clinical practice: A systematic review. Front Psychiatry. 2021;12: 628965. DOI: 10.3389/fpsyt.2021.628965.
Beaupre M, Tiwari AK, Goncalves VF, Lisoway AJ, Harripaul RS, Muller DJ, et al. Antidepressant-associated mania in bipolar disorder: A review and meta-analysis of potential clinical and genetic risk factors. J Clin Psychopharmacol. 2020;40(2):180-5. DOI: 10.1097/JCP.0000000000001186.
Zolk O, Greiner T, Scneider M, Heinze M, Dahling V, Ramin T, et al. Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study. World J Biol Psychiatr. 2022;23(5):374-86. DOI: 10.1080/15622975.2021.2011403.
Liperoti R, Sganga F, Landi F, Topinkova E, Denkinger MD, van der Roest HG, et al. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J Clin Psychiatry. 2017;78(1):e76-82. DOI: 10.4088/JCP.15m10303.
Nayak R, Rosh I, Kustanovich I, Stern S. Mood stabilizers in psychiatric disorders and mechanisms learnt from in vitro model systems. Int J Mol Sci. 2021; 22(17):9315. DOI: 10.3390/ijms22179315.
Nguyen TT, Eyler LT, Jeste DV. Systemic biomarkers of accelerated aging in schizophrenia: A critical review and future directions. Schizophr Bull. 2018;44(2):398-408. DOI: 10.1093/schbul/sbx069.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Rian Fathurrahman, Ricko Eliafiana, Arundhati Nugrahaning Aji, Dyani Pitra Velyani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
